Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis

BACKGROUND: Whether pioglitazone may affect breast cancer risk in female diabetes patients is not conclusive and has not been investigated in the Asian populations. METHODS: The reimbursement database of Taiwan’s National Health Insurance was used to enroll an unmatched cohort and a propensity score...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118720/
https://www.ncbi.nlm.nih.gov/pubmed/35585577
http://dx.doi.org/10.1186/s12885-022-09660-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118720/
https://www.ncbi.nlm.nih.gov/pubmed/35585577
http://dx.doi.org/10.1186/s12885-022-09660-8

Ejemplares similares